The FDA is mandating new labeling for opioids to better inform patients and healthcare providers about the risks of addiction, misuse, and overdose associated with long-term use.

A panel organized by the FDA cast doubts on the safety of antidepressants during pregnancy — drawing ire from doctors who say ...

These energy drinks, gummies, and supplements legally sold at gas stations and convenience stores here in the Lehigh Valley and all across the country contain an ingredient more potent than ...

The FDA has released a report to educate the public regarding the dangers of 7-OH and its distinction from the kratom plant ...

The U.S. Food and Drug Administration plans to require new labels on all opioid pain medications that emphasizes long-term ...

Laura Loomer reportedly set up a "tip line" for staffers eager to see their "disloyal" colleagues purged. Trump has been ...

The FDA is recommending that certain products containing 7-hydroxymitragynine be subject to the Controlled Substances Act.

When school starts in West Virginia next month, 240,000 students in districts large and small will notice something missing ...

The FDA has denied that it plans to combine the Center for Drug Evaluation and Research and Center for Biologics Evaluation ...

Donald Trump's controversial ally Laura Loomer has set up a tip line for administration staff frustrated by a lack of vetting ...

Yet, under federal law, it is labeled "rare" because that definition is based on prevalence —a static snapshot of how many ...